21 Ray Dalio Biomarin Pharmaceutical - Registered Shares Trades
Ray Dalio acquired 124 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $6.95 Million. That's 0.03% of their equity portfolio (298th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2014. Since then Ray Dalio bought shares thirteen more times and sold shares on seven occasions. The investor's estimated purchase price is $9.94 Million, resulting in a loss of 30%.
Avg closing price
Price range
Sold 59.1% shares (-179 Thousand shares)
Q1 2025
Avg closing price
$67.16
Price range
$61.27
-
$72.83
Increased shares by 112.5% (+160 Thousand shares)
Q4 2024
Avg closing price
$66.95
Price range
$61.93
-
$70.53
Increased shares by 306.8% (+107 Thousand shares)
Q3 2024
Avg closing price
$83.67
Price range
$69.02
-
$93.84
Increased shares by 939.3% (+31.6 Thousand shares)
Q2 2024
Avg closing price
$83.25
Price range
$74.43
-
$92.22
Sold 98.2% shares (-188 Thousand shares)
Q1 2024
Avg closing price
$89.52
Price range
$83.81
-
$99.00
Increased shares by 18.3% (+29.6 Thousand shares)
Q4 2023
Avg closing price
$88.47
Price range
$76.22
-
$98.51
Increased shares by 7.6% (+11.4 Thousand shares)
Q3 2023
Avg closing price
$88.98
Price range
$85.07
-
$94.48
Increased shares by 20.9% (+25.9 Thousand shares)
Q2 2023
Avg closing price
$94.11
Price range
$86.68
-
$100.30
Increased shares by 16.6% (+17.7 Thousand shares)
Q1 2023
Avg closing price
$103.67
Price range
$87.74
-
$117.27
Sold 1.1% shares (-1.17 Thousand shares)
Q4 2022
Avg closing price
$93.88
Price range
$80.93
-
$108.63
Increased shares by 170.8% (+67.8 Thousand shares)
Q3 2022
Avg closing price
$89.04
Price range
$82.16
-
$96.94
Increased shares by 102.1% (+20.1 Thousand shares)
Q2 2022
Avg closing price
$79.62
Price range
$71.48
-
$86.85
Increased shares by 40.5% (+5.67 Thousand shares)
Q1 2022
Avg closing price
$83.67
Price range
$74.28
-
$92.69
Sold 0.2% shares (-27 shares)
Q4 2021
Avg closing price
$82.51
Price range
$71.72
-
$91.47
Sold 39.6% shares (-9.17 Thousand shares)
Q3 2021
Avg closing price
$78.90
Price range
$74.77
-
$85.47
Increased shares by 72.5% (+9.74 Thousand shares)
Q2 2021
Avg closing price
$79.27
Price range
$75.51
-
$84.79
New holding (+13.4 Thousand shares)
Q1 2021
Avg closing price
$81.69
Price range
$74.73
-
$90.69
Sold -8.93 Thousand shares
Q4 2016
Avg closing price
$86.00
Price range
$78.62
-
$95.92
New holding (+8.93 Thousand shares)
Q3 2016
Avg closing price
$94.17
Price range
$79.86
-
$101.46
Sold -48.4 Thousand shares
Q2 2014
Avg closing price
$60.41
Price range
$56.15
-
$68.61
